Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
Kim Papp, Matthew Zirwas, Jonathan I. Silverberg, Marjolein S. de Bruin-Weller et al.
Citations
3 citations
Journal
Journal of the European Academy of Dermatology and Venereology
Topics
Dermatology and Skin Diseases
Field-Weighted Citation Impact (FWCI)
6.01
article
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
Kim Papp, Matthew Zirwas, Jonathan I. Silverberg, Marjolein S. de Bruin-Weller, Matthias Augustin, Ryszard Galus, Gretel Trullenque, Soo Yeon Cheong, Sang Wook Son, Christophe Piketty, Vivian Laquer, Andrzej Kaszuba, Ágnes Drahos, Linda Stein Gold, Liliana Ulianov, Robert Sidbury, Walter K. Nahm, M. Tauber, Adam Reich, Laura Maintz, Anna Ryzhkova, Sady Alpizar, Diamant Thaçi, Ketty Peris, Kirk Barber
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of the European Academy of Dermatology and Venereology
Institutions
Seattle Children's Hospital (US), University of Bonn (DE), Inserm (FR), Universität Hamburg (DE), University of Toronto (CA), George Washington University (US), Utrecht University (NL), Medical University of Warsaw (PL), University Hospital Bonn (DE), Agostino Gemelli University Polyclinic (IT), Orange Coast Memorial Medical Center (US), Henry Ford Hospital (US), Ansan University (KR), University of California San Diego (US), MSH Medical School Hamburg – University of Applied Sciences and Medical University (DE), Alberta Barley (CA), Merck Canada Inc. (Canada) (CA), Floridian Research Institute (US), Hospices Civils de Lyon (FR), Galderma (United States) (US), University Medical Center Hamburg-Eppendorf (DE), Synexus (Germany) (DE), Centrum Medyczne iMed24 (PL), Probity Medical Research (CA), Stedman Clinical Trials (US), West Coast Fertility Centers (US), University of the Sacred Heart (JP), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Orthopedic One (US), Centre International de Recherche en Infectiologie (FR), Galderma (Switzerland) (CH), University of Lübeck (DE), University of Rzeszów (PL)